Process evaluation for complex interventions in primary care: understanding trials using the normalization process model by May, Carl R et al.
BioMed  Central
Page 1 of 9
(page number not for citation purposes)
BMC Family Practice
Open Access Research article
Process evaluation for complex interventions in primary care: 
understanding trials using the normalization process model
Carl R May*1, Frances S Mair2, Christopher F Dowrick3 and Tracy L Finch1
Address: 1Institute of Health and Society, Newcastle University, 21 Claremont Place, Newcastle upon Tyne, NE2 4AA, UK, 2Division of General 
Practice and Primary Care, University of Glasgow, Glasgow, UK and 3School of Population, Community and Behavioural Sciences, University of 
Liverpool, Liverpool UK
Email: Carl R May* - c.r.may@ncl.ac.uk; Frances S Mair - fm46c@clinmed.gla.ac.uk; Christopher F Dowrick - cfd@liv.ac.uk; 
Tracy L Finch - tracy.finch@ncl.ac.uk
* Corresponding author    
Abstract
Background:  The Normalization Process Model is a conceptual tool intended to assist in
understanding the factors that affect implementation processes in clinical trials and other
evaluations of complex interventions. It focuses on the ways that the implementation of complex
interventions is shaped by problems of workability and integration.
Method: In this paper the model is applied to two different complex trials: (i) the delivery of
problem solving therapies for psychosocial distress, and (ii) the delivery of nurse-led clinics for
heart failure treatment in primary care.
Results: Application of the model shows how process evaluations need to focus on more than the
immediate contexts in which trial outcomes are generated. Problems relating to intervention
workability and integration also need to be understood. The model may be used effectively to
explain the implementation process in trials of complex interventions.
Conclusion:  The model invites evaluators to attend equally  to considering how a complex
intervention interacts with existing patterns of service organization, professional practice, and
professional-patient interaction. The justification for this may be found in the abundance of reports
of clinical effectiveness for interventions that have little hope of being implemented in real
healthcare settings.
Background
Getting new ways of delivering and organizing healthcare
into practice is a problem. In recent years governments
and healthcare providers across the advanced economies
have been concerned with improving the technological
and organizational capabilities of health services. At the
same time, they have sought to measure the outcomes and
costs of these interventions, in the face of constant and
increasing fiscal pressures and their political conse-
quences [1]. One result of these political and economic
pressures has been the emergence of new fields of health
research, especially health technology assessment and
health services research, that bring together clinical, social
science and statistical researchers and ally them with pol-
icy interests that demand the clinical and economic eval-
uation of already discovered treatments, technologies and
professional or organizational interventions [2,3] and
which emphasize the importance of outcomes.
Published: 24 July 2007
BMC Family Practice 2007, 8:42 doi:10.1186/1471-2296-8-42
Received: 9 January 2007
Accepted: 24 July 2007
This article is available from: http://www.biomedcentral.com/1471-2296/8/42
© 2007 May et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
Page 2 of 9
(page number not for citation purposes)
But as outcomes research has become more important, its
practitioners have also increasingly faced the problem of
conducting evaluation studies – often using randomized
controlled clinical trials – of complex  interventions. In
2000, the UK Medical Research Council (MRC) published
its Framework for the Development and Evaluation of Complex
Interventions [4]. This provides an internationally accepted
definition of complex interventions, and a robust guide to
the design of such trials.
Complex interventions in health care, whether thera-
peutic or preventative, comprise a number of separate
elements which seem essential to the proper function-
ing of the interventions although the 'active ingredi-
ent' of the intervention that is effective is difficult to
specify. (...) Complex interventions are built up from
a number of components, which may act both inde-
pendently and interdependently. The components
usually include behaviors, parameters of behaviors
(e.g. frequency, timing), and methods of organizing
and delivering those behaviors (e.g. type(s) of practi-
tioner, setting and location) [4].
The MRC framework emphasizes a staged approach to
establishing the feasibility of interventions before
embarking on large-scale evaluations. But it also recog-
nizes that the organizational and technical processes  of
implementing and delivering a complex intervention
require attention and understanding, and that these
should also be a focus of evaluation. The question of proc-
ess evaluation draws attention not only to questions of
measuring effectiveness, but also to problems of under-
standing the workability and integration of interventions
in settings that are themselves dynamic and complex
[5,6].
The development of process evaluations is important, but
is not simply a matter of developing the range of research
techniques by which they might be accomplished. The
development of conceptual models that provide interpre-
tive frameworks for process evaluations is also important.
This paper supports such a move by outlining and apply-
ing a new applied theoretical model for understanding
and evaluating the implementation of complex interven-
tions. The Normalization Process Model (NPM [7]), is an
evaluation model that asks what people do to make a com-
plex intervention workable, and to integrate it in practice.
The paper develops this by first discussing the develop-
ment of the theoretical model, and then applies it to two
case studies of complex trials that combine both treat-
ment and organizational interventions in primary care. In
the conclusion, the implications of such models for the
development of process evaluations are discussed.
Method
The MRC framework provides a methodological rather
than an explanatory approach to evaluating complex
interventions. Studies that have employed the framework,
like those conducted by Blackwood [8], or Robinson [9],
have therefore tended to adopt a procedural rather than a
theoretical approach to the problem of intervention com-
plexity. Similar methodological or procedural approaches
are encountered with other frameworks that explore, for
example, empirically identified facilitators and barriers to
the successful implementation of complex interventions
[10-12]. This means that we have to look elsewhere for
conceptual models that might help us to understand and
predict problems of workability and integration. In broad
terms, these fall into two kinds: (a) psychological models
that focus on individuals' intentions and motivations as
the prime movers in implementation processes [13-15];
and (b) sociological models that focus on collective
action and relational behavior [16-19].
Sociological perspectives offer vital insights into how
humans interact, understand, perform and organize work
collectively in healthcare. A conceptual model that drew
these insights into the field of health services research and
health technology assessment is a valuable contribution
to the development of process analyses because it focuses
on collaborative work rather than individual motivation,
and on co-operation rather than intention. Of course, psy-
chological models are designed and refined within frame-
works of prospective experimental testing and statistical
analysis, and therefore seem well suited to application in
complex trials without extensive conceptual or methodo-
logical modification [20]. Sociological theories are devel-
oped, in contrast, largely by interpretive means [21], and
so they need to be translated into terms that have a better
fit with the specific demands of process evaluations, and
the requirement for prospective or predictive tests that
stem from these. In this context, the NPM is a sociological
model that is suitable for prospective process evaluations of
complex interventions.
The model proposes that while measurable effectiveness
or superiority in outcomes has obvious importance, the
success of a complex intervention must also be under-
stood in relation to the workability and integration of it
components in practice. This stems from the longstanding
observation that the performance of everyday tasks is
made possible by their routinization over time, and their
assimilation or embedding as taken-for-granted elements
of everyday action [22-24]. Thus, a complex intervention
that is completely workable and integrated becomes rou-
tinely embedded in health care work, and minimally dis-
rupts social relations and behavior around it. The work of
normalization is thus about achieving ecological success,
and not clinical or cost effectiveness.BMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
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The development of the model, and a detailed account of
its constructs, their dimensions and components, has
been given elsewhere [7]. In its simplest form, it proposes
that complex interventions are implemented in processes
in which the collective action and interactions of patients,
professionals and others are governed by four factors.
Each factor suggests a proposition that may be applied to
the assessment and evaluation of an intervention
(i) Interactional workability
This refers to how work is enacted by the people doing it.
A complex intervention will affect co-operative interac-
tion over work (congruence), and the normal pattern of
outcomes of this work (disposal). Therefore:a complex
intervention is disposed to normalization if it confers an inter-
actional advantage in flexibly accomplishing congruence and
disposal of work.
(ii) Relational integration
This refers to how work is understood within the networks
of people around it. A complex intervention will affect not
only the knowledge required by its users (accountability),
but also the ways that they understand the actions of peo-
ple around them (confidence). Therefore:a complex inter-
vention is disposed to normalization if it equals or improves
accountability and confidence within networks.
(iii) Skill-set workability
This refers to the place of work in a division of labor. A
complex intervention will affect the ways that work is
defined and distributed (allocation), and the ways in
which it is undertaken and evaluated (performance).
Therefore: a complex intervention is disposed to normalization
if is calibrated to an agreed skill-set at a recognizable location
in the division of labor.
(iv) Contextual integration
This refers to the organizational sponsorship and control
of work. A complex intervention will affect the mecha-
nisms that link work to existing structures and procedures
(execution), and for allocating and organizing resources
for them (realization). Therefore: a complex intervention is
disposed to normalization if it confers an advantage on an
organization in flexibly executing and realizing work.
Set out in this way, the model offers a set of general
descriptions of those factors that might affect normaliza-
tion processes and outcomes in the context of a trial or
other evaluation of a complex intervention, and that
might also be expected to affect non-experimental man-
agement interventions in healthcare settings. It also offers
a set of propositions that can form the basis of testable
hypotheses about observable activities with measurable
outcomes. In the NPM, it is collective action and not indi-
vidual motivation that is the focus of evaluating complex
interventions and assessing their probable outcomes. The
next section of the paper explores its application to two
bodies of research around the effectiveness and imple-
mentation of complex interventions – problem solving
therapies for people with depression and nurse-led heart
failure clinics in primary care.
Results
So far, we have defined normalization and the factors that
govern it. Because the NPM is about what different groups
of people collectively do in healthcare settings rather than
what they individually intend to do, it proposes that most
healthcare work – no matter how autonomous the indi-
vidual practitioner – is undertaken in the context of com-
plex and dynamic collective interactions. Case studies of
randomized controlled trials of complex interventions in
primary care form useful opportunities to explore at a gen-
eral level how the NPM might be applied. In what follows
we draw on two such examples. These are:
a. Trials of Problem Solving Therapies (PST) for psychoso-
cial problems. This is a new treatment modality that also
involves changes in the organization and division of labor
in healthcare;
b.  A trial of a nurse-led clinic for the management of
Chronic Heart Failure that involved changes in the divi-
sion of labor (shifting work from primary care physicians
to nurses) and the structure of work itself, in the imple-
mentation of a clinical guideline.
These examples provide a focus for considering two of the
major types of chronic health problems that health care
systems respond to – chronic psychosocial problems, and
chronic and degenerative organic disease.
Evidence for primary care interventions
In both of the cases under examination there is strong evi-
dence from different kinds of outcomes studies that com-
munity based interventions are clinically effective. The
least contentious of these is Chronic Heart Failure. This is
a common condition, affecting 0.8 – 3.9 % [25,26] of the
general population and 8–10 % of those over 65 years of
age. It represents a major public health problem because
of its associated high levels of morbidity and mortality
and negative impacts on quality of life. Moreover, it is a
malignant condition with a poor prognosis and life
expectancy worse than most common cancers [27]. Over
recent years there have been many important advances in
the approach to both diagnosis and management of heart
failure, particularly heart failure due to left ventricular
systolic dysfunction. The importance of accurate diagno-
sis has been emphasized and a number of therapeutic
agents, particularly angiotensin converting enzyme inhib-
itors, beta blockers and spironolactone have been shownBMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
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in large scale randomized controlled clinical trials to
improve morbidity, mortality and quality of life [28,29].
These trials have led to well founded clinical guidelines
[30-32] which make clear recommendations for both
diagnosis and treatment of people with this condition.
However, despite the evidence and the widespread availa-
bility and dissemination of these clinical guidelines the
management of heart failure remains suboptimal [33].
There are a range of explanations for this ranging from the
presence of multiple co-morbidities, increasing the com-
plexity of management of the condition, and posing
adherence challenges, through to the general lack of
organized, systematic, mechanisms for monitoring and
follow up for this patient population.
In contrast, Problem Solving Therapy (PST) is based on
the observation that emotional symptoms are generally
induced by problems of living, and has its theoretical
roots in cognitive-behavioral approaches to mental disor-
ders [34]. PST has been developed as a specific, collabora-
tive treatment, with three main steps: first, patients'
symptoms are linked with their problems; second, the
problems are defined and clarified; and third, an attempt
is made to solve the problems in a structured way with the
aim of reasserting control over their lives, and it may be
this regaining of control which lifts mood [35]. This proc-
ess usually involves six sessions with a therapist, with a
total contact time of less than four hours [36]. In rand-
omized controlled trials, PST has been shown to be of
comparable efficacy to antidepressant medication in the
treatment of major depression when delivered by experi-
enced general practitioners [37], and in the treatment of
dysthymia (though not minor depression) in adults aged
18–59 when delivered by psychologists with PhDs [38].
The skills needed to deliver PST can be rapidly acquired by
a range of health professionals including general practi-
tioners, nurses and psychologists. In the USA it has
demonstrable clinical effectiveness and cost-effectiveness
when delivered by depression care managers as part of a
package of care for older people [39,40]. Although it is not
cost effective when delivered by specialist community psy-
chiatric nurses for undifferentiated common mental
health problems [41], PST has been shown to be effective
when delivered in patients' own homes by trained facilita-
tors with qualifications in psychology, nursing or allied
health professions; and to be more effective than treat-
ment as usual for people in five European countries with
depressive and adjustment disorders identified through
community survey [42].
Interactional workability: the problem of congruence and 
disposal
The starting point for comparative analysis of the PST and
Heart Failure Clinics trials is their interactional workability.
This construct defines the dimensions of the immediate
social context in which a complex intervention is enacted.
In the UK, and elsewhere, there has been a shift to seeing
the management of chronic illness as not only being more
clinically effective and socially equitable when under-
taken in primary care [43], but also as being more interac-
tionally efficient because of its presumed continuity of
care and holistic character [44]. This shift continues,
although there has been a steady trend in UK primary care
– and that of some other countries – towards more frag-
mented encounters focused through task, rather than per-
son, oriented interactions and located in complex
divisions of labor [45] and organizational settings [46].
In the case of PST, there appears to be considerable con-
gruence between public preferences for psychological
rather than drug treatments for depression [47] and those
of its proponents. But in trials of PST, variable up-take of
the treatment is a problem – 63% in the ODIN study [42];
80% in the dysthymia study [38]; and 62% in the commu-
nity psychiatric nurse study [41] – suggests that in practice
congruence between professional and patient is far from
complete, and that effective disposal is therefore unlikely
in a substantial minority of cases. This suggests that not all
patients share the expectations or meaning inherent in
PST, or accept its legitimacy. This may, for example, be
because some are more comfortable with treatment
modalities such as medication that tend to absolve them
from responsibility for their condition [48].
In considering its interactional workability, the question of
whether PST confers an interactional advantage over exist-
ing therapies in accomplishing congruence in encounters
between health professionals and patients, and hence
more efficient disposal of work, is a complex one, because
of the lack of observational data and the question of
whether uptake of treatment is a good proxy measure.
However, the hypothesis underlying PST, that emotional
symptoms are generally induced by problems of living; its
object, to increase patients' abilities to solve their prob-
lems; and provide a means to achieve this – six structured
sessions with a therapist – completely rely on shared
notions of legitimate conduct, and co-operation within
clinical encounters. This means that outcomes of PST are a
powerful proxy for its interactional workability.
We face a similar problem of proxy measures in the Heart
Failure Clinics Trial [49]. This trial sought to respond to
the problem of suboptimal care for older people with
chronic heart failure. Other trials of specialist nurse inter-
ventions for heart failure patients have been undertaken
and have demonstrated that such interventions can
decrease hospital readmission rates, mortality and also
improve quality of life [50]. The nurse-led heart failure
clinics instituted in this trial involved the implementationBMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
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of accepted guidelines in a structured way, a mode of prac-
tice with which practice nurses are accustomed and profi-
cient. Patients too, are accustomed to nurse led primary
care clinics where nurses substitute for family physicians
[51-53]. It is also well established that patients respond
well to practice nurses delivering routine chronic disease
management services – nurses are viewed, for example, as
being more holistic and informal in their approach, and
as giving more time to interactional tasks [54].
Like PST, trial outcomes in nurse led heart failure clinics
can be seen as a partial proxy for workability. Improved
process measures, such as increased use of appropriate
medications implies co-operation within clinical encoun-
ters. However, qualitative data draws attention to the lack
of congruence between professionals and patients over
the significance of CHF, and therefore over the impor-
tance of its clinical management [55,56]. Some patients
simply did not understand the magnitude of their disease
– either because it had not previously been disclosed to
them in a way that they found comprehensible, or in a
smaller number of cases, because they were unaware of
their diagnosis, and thus failed to attend the clinic, mean-
ing that congruence was not complete. Also, patients' lack
of understanding of their condition meant that effective
disposal within the clinic could be challenging as a good
deal of remedial work was required on the part of the
nurses delivering the service.
Relational integration: accountability, confidence and 
trust
Health professionals' accounts of their practice typically
take the important business of dealing with, and dispos-
ing of, patients' problems as a priority [57]. Equally,
accounts of the design and outcomes of trials and other
evaluations of complex interventions focus, for obvious
reasons, on the intervention and its outcomes rather than
on the processes by which these are obtained [5]. This
makes it difficult to explore those aspects of complex
intervention trials that involve 'hidden work' [58], and
becomes important when we seek to understand their
relational integration. Relational integration signifies the
need to understand not only the possession and dispersal
of knowledge needed to successfully utilize a complex
intervention, but also the ways that those users under-
stand and have confidence in the knowledge of people
around them. In retrospective analyses like this one, the
question of baseline knowledge and further training can
be considered as a proxy measure for individual users –
although it is of limited value in understanding processes
of collective action.
When patients entered the heart failure clinics trial, the
management protocols and techniques that nurses
employed were based on clinical guidelines. But nurses
required additional training and ongoing professional
support to help them acquire and feel comfortable with
their level of knowledge in this sphere. This improved
their individual expertise and accountability by providing
a strong theoretical background to heart failure – in other
words the training was focused on the knowledge under-
pinning the intervention (the guideline) rather than its
application in clinical interactions. This explains why
nurses felt inadequately prepared for the practicalities of
seeing patients with complex problems in the clinic. Thus,
in the initial stages of the trial remedial work needed to be
done, because professionals delivering the intervention
expressed concerns about their confidence in delivering
the intervention. The patients on the other hand,
expressed confidence in the health professionals and felt
that the intervention gave them greater confidence in
managing their health. Qualitative data collected in this
trial focused mainly on 'lay perceptions' of heart failure
and lay evaluations of the clinic [56], but this data does
indicate that professionals' accountability and confidence
in knowledge seemed to be improved by the intervention.
Training needs cannot be a proxy for relational integra-
tion in the case of PST, since by definition entry into this
work is dependent on specialized training and accredita-
tion. As a treatment modality PST fits with, and even
extends, established patterns of knowledge about the etiol-
ogy and management of depression in primary care, and
seems therefore to have greater potential for relational
integration. In general, health professionals working in
primary care tend to believe that problems of living are
significant in the genesis of depression, and that knowl-
edge of them is helpful in deciding on treatment options
[41]. But how PST is integrated in any given intervention
setting depends on who delivers the service. We know that
there are differences in the way that knowledge is pat-
terned within particular professional groups, and there are
important debates to be had about what kinds of practi-
tioner is best suited to deliver this kind of care. These
debates become steadily more important as the epidemic
of depression and anxiety seems to grow [59]. As it stands,
questions about the focus of training and delivery of PST
focus on: primary care physicians, who are limited in
number, and have high patient credibility, but who work
within significant constraints on time and effectiveness
[60]; other healthcare professionals such as psychologists,
nurses or counselors, whose interventions can be equally
shown to be effective, but who are in equally short supply;
or new breeds of professionals, such as depression care
managers or graduate mental health workers [61].
Skill-set workability: who should do this work?
Interactional workability and relational integration are
constructs that refer to the endogenous factors affecting a
complex intervention. This means that they are concernedBMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
Page 6 of 9
(page number not for citation purposes)
with the immediate contexts in which different kinds of
agents, and the objects of their agency, encounter each
other. Thus, they are the immediate concern of those who
propose and deliver complex intervention trials. But the
wider context in which these encounters are set is no less
crucial to their conduct. This involves exogenous factors
which derive from the ecology in which they are set. These
cannot be assumed, but merit an equal degree of attention
from evaluators.
The first exogenous factor is reflected in the construct of
skill-set workability, the extent to which a complex interven-
tion is calibrated to an agreed set of skills in the health
care division of labor. In the Heart Failure Clinics trial,
this was relatively uncontentious. We have already noted
that the delegation of medical work previously under-
taken by primary care physicians to nurses is a normal fea-
ture of chronic disease management in the UK [53], and it
figures prominently in questions of performance and
quality [62,63]. This means that the division of labor
within this service was congruent with established modes
of working within primary care. Practice nurses delivered
a guideline driven chronic disease clinic, and primary care
physicians were drawn into this work when specific treat-
ment changes were required or further advice needed to
be sought. Despite this, some problems of communica-
tion between the practice nurses and general practitioners
were noted. This may have been exacerbated by the fact
that the training for the service was primarily, although
not exclusively directed towards the nurses rather than the
general practitioners. Thus there were occasions when
nurses suggested treatment changes in accordance with
the clinical guidelines, but changes were not accepted or
enacted by the general practitioners. Skill set workability
was therefore at times problematic from the perspective of
at least one group of participants.
While the Heart Failure Clinics trial operated within the
frame of a conventional model of nursing work, the deliv-
ery of PST is more contentious. It is by no means clear
which type of health professional is most likely to deliver
it, and thus how it might be calibrated to the professional
division of labor in healthcare. Thus there remain unre-
solved questions about the allocation of work – and con-
sequent levels of performance- between primary care
physicians, other already existing healthcare profession-
als, and new members of primary healthcare teams. If gen-
eral practitioners are to undertake this work for example,
then the sense of professional autonomy will be high and
surveillance is likely to be minimal; whereas if graduate
mental health workers do so, autonomy is likely to be rel-
atively low, and expectations for managerial surveillance
consequently much greater. This means that the skill-set
workability of PST is presently low in the settings sug-
gested by the trials upon which this part of the paper
focuses [37-40]. Although such resistance may well be
related to concerns about job retention, it is more likely to
be expressed in terms of role uncertainty. Existing health-
care professionals, when invited to comment on plans for
a new collaborative care model for depression which
would include case managers with skills in PST, express a
wide variety of concerns. These include uncertainty about
the professional values of the new workers, fears about
their experience and competence, and statements about
the need for education in non-specific skills necessary to
develop a therapeutic alliance, as well as the knowledge
and skills required for education, medication support and
behavioral activation [64].
Contextual integration: not just a problem of funding
It was noted above that conventional modes of reporting
trials and locating qualitative studies within them provide
limited information about processes. This becomes espe-
cially important when we focus our attention on the ways
that a complex intervention 'fits' with the operational
environment in which it is set. The Normalization Process
Model proposes that a complex intervention will affect
the mechanisms that link work to existing structures and
procedures (its execution), and for allocating and organiz-
ing resources for them (its realization). But of course trials
of complex interventions are normally carefully divided
from the normal features of the environment in which
they are set. One way to explain this is to say that they are,
after all, only temporary and often unstable experiments
that are overlaid on often very deeply embedded organi-
zational and professional systems of practice. Further-
more, the demands of the trial protocol mean that this
work of division is ongoing, so that the trial is not con-
taminated by those environmental features. But the inte-
gration of a complex intervention at an organizational
level – its contextual integration – is much more than this.
Other work [58], has shown this to be a crucial factor in
the successful implementation of such interventions.
The absence of process evaluations that seek to under-
stand the interactions between a complex intervention
and its organizational context is important. In this area,
proxies are very hard to come by. Perhaps the most obvi-
ous is the economic evaluation which contextualizes an
intervention in terms of its costs, rather than its business
processes. In our two case studies, we can only speculate
about their potential for contextual integration. In the
case of PST answers to this question will depend critically
on what resource allocation models are employed. From
the perspective of healthcare commissioners, it would
appear most cost-effective to place the delivery of PST in
the hands of new breeds of healthcare providers, such as
depression care managers or graduate mental health
workers, since these tend to be less qualified and hence
less expensive. In a situation of expanding resource alloca-BMC Family Practice 2007, 8:42 http://www.biomedcentral.com/1471-2296/8/42
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tion, such a shift would be unlikely to be seen as prejudi-
cial by general practitioners or existing healthcare
professionals, but may rather be welcomed as an addi-
tional resource [65]. However in the more common situ-
ation where resource for healthcare is finite or even
decreasing, any consequent shift in allocation would be
likely to meet resistance from existing healthcare staff.
In the case of the Heart Failure Clinics trial the answer to
this question may depend on the extent to which such sys-
tematic monitoring of heart failure patients in the com-
munity is seen as a central function of primary care both
by the primary care professionals themselves and by exter-
nal health care organizations. Importantly, this may be
reflected in the degree to which such monitoring is
rewarded through contractual arrangements in primary
care. Thus the execution of such a service will depend to a
large extent on how such work is valued or not at a health
care systems level. This type of intervention is extremely
labor intensive and the priority given to resourcing such
initiatives are likely to be greatly influenced by prevailing
economic factors.
Conclusion
This paper has done three things. First, it has pointed to
the need for sound process evaluations in trials of com-
plex interventions and other implementation studies. Sec-
ond, it has set out the basic features of a robust conceptual
model that provides a sound explanatory basis for process
evaluations. Third, it has applied the model retrospec-
tively to trials of complex interventions in mental health
and heart disease. We now turn to the question of interac-
tion between complex interventions and their contexts.
The most important consideration here is that the inter-
ventions discussed in this paper are competing with exist-
ing, deeply embedded, and thoroughly normalized
modes of practice. While the trial assesses the relative
effectiveness, and sometimes the relative cost-effective-
ness of competing models of practice – the superiority of
one over the other – process evaluations need to be con-
cerned with their relative workability and integration.
The model invites evaluators to attend equally  to four
domains that have been shown to be of central impor-
tance to effective implementation. This is particularly
important in considering how a complex intervention
interacts with existing patterns of service organization,
professional practice, and professional-patient interac-
tion. Such an approach has a further important effect,
which is to set out the implementation and integration of
complex interventions as organizational or business proc-
esses that are as important to assess as clinical and cost
effectiveness. It is important to note that this is not an
appeal for more social science research within clinical and
health technology assessment trials. Instead it suggests
how trialists can engage with the complex dynamics of the
settings in which they hope that their interventions will be
implemented. This requires that the theory and methods
of the social sciences are treated as integral elements in
complex intervention trials. The justification for this may
be found in the abundance of reports of clinically effec-
tiveness interventions that have little hope of being imple-
mented in real healthcare settings.
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